Page 1429 - Problem-Based Feline Medicine

1422 INDEX

Cyclophosphamide, (continued) lymphadenopathy, 418 Cytotoxic drugs
eosinophils, 97 pathogenesis, 535 feline infectious peritonitis, 82
toxicity, 175, 191–192 transmission, 535 inflammatory bowel disease,
Cyclosporine, 1364 treatment, 535 idiopathic, 715, 746
atopic dermatitis, 1031 zoonotic potential/prevention, 535 megakaryocytic hypoplasia, 496
eosinophilic granuloma complex, Cythioate, 1364 pulmonary infiltrates with
587, 1088 Cytological examination/evaluation eosinophils, 97
immune-mediated hemolytic asthma, 93
D
anemia, 533 fibrosarcoma, 1072
immune-mediated tuberculosis in non-healing wounds, Dacarbazine, 1364
thrombocytopenia, 507 1094 Dactinomycin, 1364
inflammatory bowel disease, 310 Cytologic examination, ruptured bile Daffodil poisoning, 284
oral inflammatory disease, 585 duct, 441 Dalteparin, 1364
toxic erythema multiforme/erythema Cytology DAMNPIT acronym, 2–3
multiforme, 1106 autoimmune dermatoses, 1043 Danazolol, 1364
Cyclothiazide, 1364 bacterial rhinitis, secondary, 22 Dapsone, 1364
Cyproheptadine, 1364 bacterial ulcerative keratitis, D-dimer measurement, disseminated
feline asthma, 95 1248–1249 intravascular coagulation, 502
feline infectious peritonitis, 82 cranial mediastinal lymphosarcoma, Death Adder (Acanthophis antarcticus)
feline rhinotracheitis virus, 9 115 envenomation, 950–953
hemorrhage, 521 cryptococcosis, 16, 26, 37, 1089, Decerebellate rigidity, 932
spraying, 1014 1175, 1269 Declawing complications, 1110, 1120
Cysterna chyli, 78 eyelid/conjunctiva squamous cell Decongestants, 9
Cystic endometrial hyperplasia, 233, carcinoma, 1217–1218 Deep episcleral vessel injection, 1178
259–260, 1152–1153, 1161–1162 feline herpes virus-1 keratitis, 1239, Deep wedge biopsy, 1116
clinical signs, 1152, 1161 1260 Defecation, inappropriate, 1012, 1013
diagnosis, 1152, 1161–1162 feline infectious peritonitis, 457 Defecation posture, 783
differential diagnosis, 1152, 1162 granulomatous bacterial infections, Deferoxamine mesylate, 1364–1365
infertile queen, 1146, 1152–1153 408 Degenerative joint disease, 976, 981
pathogenesis, 1152, 1161 hemangioma/hemangiosarcoma, Degenerative motor neuropathy, 941,
polyuria/polydipsia, 259–260 1075 964
prevention, 1153, 1162 hepatic lipidosis, 426 Degenerative myopathy, 942, 964–966
prognosis, 1153, 1162 herpes conjunctivitis, 1213 Degenerative neuropathy, 941,
treatment, 1152, 1162 infectious pododermatitis, 1112 963–964
vaginal discharge, 1160, 1161–1162 intestinal tuberculosis, 470 Dehydration, 261–300, 557–560,
Cystine crystals/urolithiasis, 186, 214 intranasal tumors, 36 787–788
Cystitis mycobacterial infections in non- causes, 266–299
idiopathic, 174, 176–179 healing wounds, 1086 clinical signs, 553, 557, 782, 788
see also Lower urinary tract Mycoplasma conjunctivitis, 1219 constipation/straining, 782, 787–788
disease (LUTD) otitis media-interna, 841 definition, 266
infectious, 174, 187–189 pneumonia, 104 diagnosis, 557, 788
Cystocentesis, 183, 463–464 pulmonary infiltrates with differential diagnosis, 557, 788
Cystoscopy, 177, 209 eosinophils, 97 feline rhinotracheitis virus, 8
Cystotomy, 186 pyothorax, 77 hepatic lipidosis, 427
Cysts see specific types sporotrichosis in non-healing hypokalemic myopathy, 894
Cytarabine, 1364 wounds, 1095 mechanisms of, 265, 266
Cytauxzoon felis, 366, 389, 535 Staphylococcal dermatitis, 1041 pathogenesis, 557, 787–788
see also Cytauxzoonosis sweat gland neoplasia, 1078 polycythemia, 553, 557–560
Cytauxzoonosis, 396, 418, 534–535 third eyelid squamous cell post-diuretic therapy, 131
anemia, 534–535 carcinoma, 1334 prognosis, 560, 788
clinical signs, 527, 534–535 Cytoplasmic vacuolation, cholesterol treatment, 557–560, 788
diagnosis, 535 ester storage disease, 576 Demeclocycline, 1365
differential diagnosis, 535 Cytosine arabinoside, 910, 918 Demodex, 1112